BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30832458)

  • 1. Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis.
    Pyo JS; Kim NY; Cho WJ
    J Pathol Transl Med; 2019 May; 53(3):173-179. PubMed ID: 30832458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
    Pyo JS; Kim NY; Min KW; Kang DW
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512068
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic role of PD-L1 in malignant solid tumors: a meta-analysis.
    Pyo JS; Kang G; Kim JY
    Int J Biol Markers; 2017 Mar; 32(1):e68-e74. PubMed ID: 27470134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
    Xia Y; Wei X; Gong H; Ni Y
    BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
    Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
    Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Significance Role of microRNA-200c as a Prognostic Factor in Various Human Solid Malignant Neoplasms: A Meta-Analysis.
    Wang F; Zhang L; Xu H; Li R; Xu L; Qin Z; Zhong B
    J Cancer; 2019; 10(1):277-286. PubMed ID: 30662548
    [No Abstract]   [Full Text] [Related]  

  • 8. The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies.
    Xu L; Zhang Y; Tang J; Wang P; Li L; Yan X; Zheng X; Ren S; Zhang M; Xu M
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):867-881. PubMed ID: 30602498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of interleukin-17 in solid tumors: a meta-analysis.
    Zeng Y; Zhang Q; Wang H; Lu M; Kong H; Zhang Y; Shi H
    Int J Clin Exp Med; 2015; 8(7):10515-36. PubMed ID: 26379842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
    Lin SC; Gan ZH; Yao Y; Min da L
    PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.
    Petrelli F; Viale G; Cabiddu M; Barni S
    Breast Cancer Res Treat; 2015 Oct; 153(3):477-91. PubMed ID: 26341751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of intratumoral IL-17A expression by immunohistochemistry in solid tumors: a meta-analysis.
    Wang S; Li Z; Hu G
    Oncotarget; 2017 Sep; 8(39):66382-66391. PubMed ID: 29029520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic and prognostic significance of C-reactive protein/albumin ratio in patients with solid tumors: an updated systemic review and meta-analysis.
    Wu J; Tan W; Chen L; Huang Z; Mai S
    Oncotarget; 2018 Mar; 9(17):13934-13947. PubMed ID: 29568406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of Claudin-4 in gastric cancer tissue: A single center experience.
    Moris D; Schizas D; Michalinos A; Kanavidis P; Dimitrokallis N; Alexandrou A; Misiakos E; Liakakos T
    J BUON; 2017; 22(2):403-409. PubMed ID: 28534362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
    Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
    Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
    Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
    Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Bcl-2 expression with prognosis and survival in patients with head and neck cancer: A systematic review and meta-analysis.
    Silva FFVE; Caponio VCA; Camolesi GCV; Padín-Iruegas ME; Lorenzo-Pouso AI; Lima KC; Vieira SLS; Chamorro-Petronacci CM; Suaréz-Peñaranda JM; Pérez-Sayáns M
    Crit Rev Oncol Hematol; 2023 Jul; 187():104021. PubMed ID: 37210016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance and concordance analysis of c-MET immunohistochemistry in non-small cell lung cancers: A meta-analysis.
    Pyo JS; Kang G; Cho WJ; Choi SB
    Pathol Res Pract; 2016 Aug; 212(8):710-6. PubMed ID: 27465837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Effect of Albumin-to-Globulin Ratio in Patients with solid tumors: A Systematic Review and Meta-analysis.
    He J; Pan H; Liang W; Xiao D; Chen X; Guo M; He J
    J Cancer; 2017; 8(19):4002-4010. PubMed ID: 29187875
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic value of FOXQ1 in patients with malignant solid tumors: a meta-analysis.
    Cui X; Zhang J; Lv J; Yan Y; Liu X; Wang J; Lv Y; Zhang J
    Onco Targets Ther; 2017; 10():1777-1781. PubMed ID: 28367060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.